the time-varying survival benefit of hcc treatment a multicenter cohort study参考.pdf

e8 Abstracts / Digestive and Liver Disease 51 (2019) e1–e17
OC-14 OC-15
The time-varying survival benefit of HCC NASH-related liver carcinogenesis is critically
treatment: a multicenter cohort study affected by hypoxia-inducible factor 2␣
A. Vitale 1, G. Maddalo 1, F. Trevisani 2, F. Farinati 1 B. Foglia 1, S. Sutti 1,2, E. Morello 1, S. Cannito 1,
E. Novo 1, C. Bocca 1, M. Maggiora 1, S. Bruzzì 2,
1 Department of Surgery, Oncology and
. Ramavath 2, C. Rosso 3, R. Younes 3,
Gastroenterology, University of Padua, Padua, Italy
E. Bugianesi 3, E. Albano 2, M. Parola 1
2 Department of Medical and Surgical Sciences,
Division of Semeiotics, Alma Mater Studiorum – 1 Department Clinical and Biological Sciences, Italy
University of Bologna, Bologna, Italy 2 Department Health Sciences, A. Avogadro
Univer